Biological treatment of Rheumatoid Arthritis
-
Upload
abdullatif-al-rashed -
Category
Health & Medicine
-
view
1.278 -
download
0
Transcript of Biological treatment of Rheumatoid Arthritis
![Page 1: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/1.jpg)
Biological Agents As A Treatment of Rheumatoid
Arthritis Abdullatiff Sami Al-RashedConnective Tissue Disorders Elective212516770College of Medicine, King Faisal UniversityAl-Ahsa, Saudi Arabia
![Page 2: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/2.jpg)
Introduction • Biologic Agents are drugs that are genetically
engineered from a living organism, such as a virus, gene or protein, to simulate the body’s natural response to infection and disease.
• They target proteins, cells and pathways responsible for the symptoms and damage of rheumatoid arthritis and other types of inflammatory arthritis.
![Page 3: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/3.jpg)
Types
![Page 4: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/4.jpg)
TNF Inhibitors
1. Etanercept– It is a recombinant version of soluble human TNF receptor that
binds specifically to tumour necrosis factor and blocks its interaction with endogenous cell-surface TNF receptors.
– It is effective for the treatment of a number of forms of inflammatory arthritis and other conditions, including RA, psoriatic arthritis, and ankylosing spondylitis.
– Administered once or twice weekly via subcutaneous injection.
![Page 5: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/5.jpg)
TNF Inhibitors
2. Infliximab: – Infliximab is a chimeric monoclonal antibody to TNF α. The
term “chimeric” refers to the use of both murine and human components of the drug.
– It is used with methotrexate in the management of moderate to severe, active rheumatoid arthritis.
– Administered via intravenous infusion approximately every six weeks once a steady state has been achieved.
![Page 6: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/6.jpg)
Other TNF Inhibitors
AdalimumabcertolizumabGolimumab
![Page 7: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/7.jpg)
IL-Inhibitors
• Anakinra:– Anakinra, a recombinant human IL-1Ra.– Significantly less potent than TNF inhibitors in most
patients.– NOT recommended in a combination regimen with a
TNF inhibitor because of an increased frequency of serious adverse events, including serious infections
![Page 8: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/8.jpg)
B-Cell Inhibitors• Rituximab:
– It is a chimeric monoclonal antibody that binds specifically to the CD20 antigen.
– Used mainly for treatment of non-Hodgkin's lymphomas and CML.
– In the treatment of rheumatoid arthritis, rituximab is given in a dose of 1 g, for 2 doses; the infusions are separated by 2 weeks. It is given with methotrexate, and intravenous corticosteroids are recommended before each infusion to reduce the incidence and severity of infusion reactions.
![Page 9: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/9.jpg)
Selective co-stimulation modulators
• Abatacept:– Abatacept, a fusion protein, is a co-stimulation blocker.
– It has been approved by the United States Food and Drug Administration for the treatment of patients with moderately to severely active RA who have had an inadequate response to one or more disease modifying antirheumatic drugs (DMARDs)
or tumor necrosis factor (TNF) inhibitors.
![Page 10: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/10.jpg)
Side Effects
![Page 11: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/11.jpg)
APPROACH TO THE MANAGEMENT of Ra
![Page 12: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/12.jpg)
Establish Early Diagnosis
Clinical
EULAR
Start DMARD
(Methotrexate)Monitor response
Continue with MTX(7.5MG/Wk upto 17.5-20MG/WK
Comb DMARDS
Add Biologics
NOYES
![Page 13: Biological treatment of Rheumatoid Arthritis](https://reader034.fdocuments.us/reader034/viewer/2022050614/588ab0401a28ab4c308b708d/html5/thumbnails/13.jpg)